Clinical Outcomes of Aberration-Free All Surface Laser Ablation (ASLA) vs. Aberration-Free ASLA Assisted by Smart Pulse Technology in High Myopia: A One-Year Follow-Up Study

Table 2

Visual acuity and refraction outcomes^a.

Parameter	Group	Preoperative	12 months
LogMAR UDVA	SPT	1.294 ± 0.245	−0.040 ± 0.054	0.533
	Non-SPT	1.280 ± 0.269	−0.009 ± 0.080
LogMAR CDVA	SPT	−0.007 ± 0.017	−0.046 ± 0.045	0.004^b
	Non-SPT	−0.024 ± 0.034	−0.038 ± 0.041
Sphere	SPT	−7.60 ± 1.31	0.24 ± 0.50	0.770
	Non-SPT	−7.60 ± 1.06	0.26 ± 0.51
Cylinder	SPT	−0.83 ± 0.64	−0.45 ± 0.34	0.169
	Non-SPT	−1.00 ± 0.71	−0.42 ± 0.28
Spherical equivalent	SPT	−8.02 ± 1.32	0.01 ± 0.47	0.493
	Non-SPT	−8.10 ± 1.05	0.05 ± 0.50

SPT = smart pulse technology; UDVA = uncorrected distance visual acuity; CDVA = corrected distance visual acuity. ^aValues are presented as mean ± standard deviation. ^bSignificant difference between the SPT and non-SPT groups (Student’s t-test/Mann–Whitney U-test).